切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2020, Vol. 14 ›› Issue (04) : 306 -309. doi: 10.3877/cma.j.issn.1674-0785.2020.04.013

所属专题: 文献

综述

18F-FDG PET-CT在食管癌放射治疗靶区勾画中的应用进展
刘红丽1, 许雪冬2, 邵倩3,()   
  1. 1. 250102 济南大学山东省医学科学院医学与生命科学学院 济宁肿瘤医院肿瘤三科
    2. 271000 山东泰安,泰山医学院
    3. 250117 济南,山东省肿瘤防治研究院(山东省肿瘤医院)放疗科,山东第一医科大学(山东省医学科学院)
  • 收稿日期:2019-03-16 出版日期:2020-04-15
  • 通信作者: 邵倩

Application of 18F-FDG PET-CT in delineation of target volume for radiotherapy of esophageal cancer

Hongli Liu1, Xuedong Xu2, Qian Shao3,()   

  1. 1. School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences; the Third Department of Oncology, Jining Tumor Hospital, Jinan 250102, China
    2. Taishan Medical University, 271000 Tai’an, China
    3. Department of Radiation Oncology, Shandong Cancer Research Institute (Shandong Cancer Hospital), Shangdong First Medical University (Shandong Academy of Medical Sciences), Jinan 250117, China
  • Received:2019-03-16 Published:2020-04-15
  • Corresponding author: Qian Shao
  • About author:
    Corresponding author: Shao Qian, Email:
引用本文:

刘红丽, 许雪冬, 邵倩. 18F-FDG PET-CT在食管癌放射治疗靶区勾画中的应用进展[J/OL]. 中华临床医师杂志(电子版), 2020, 14(04): 306-309.

Hongli Liu, Xuedong Xu, Qian Shao. Application of 18F-FDG PET-CT in delineation of target volume for radiotherapy of esophageal cancer[J/OL]. Chinese Journal of Clinicians(Electronic Edition), 2020, 14(04): 306-309.

放射治疗是食管癌的重要治疗方法,而精准的靶区勾画是决定放射治疗疗效的前提和基础,靶区勾画是以CT为基础的多种影像学信息资料,本文将对正电子发射断层显像(PET-CT)分子功能影像在食管癌及其转移淋巴结的靶区勾画中的应用进行综述,以充分发挥PET-CT在食管癌原发病灶及淋巴结转移靶区勾画方面的重要作用。

Radiotherapy is an important treatment for esophageal cancer, and accurate delineation of target volume is the premise and basis for ensuring the efficacy of radiotherapy. The delineation of target volume is based on a variety of computed tomography (CT) imaging information. This paper will review the application of positron emission tomography/CT (PET-CT) in the delineation of target volume for radiotherapy of esophageal cancer and its metastatic lymph nodes, with an aim to emphasize the important role of PET-CT in delineating the primary lesion and lymph node metastasis of esophageal cancer.

1
Zhang G, Han D, Yin Y. Using the Gradient-based Method to Delineate the Primary GTV on FLT-PET in Esophageal Carcinoma and Discussing the Influence on Radiotherapy Planning[J]. Int J Radiat Oncol Biol Phys, 2011, 81(2 Suppl): S315-S316.
2
Buchmann I, Haberkorn U, Schmidtmann I, et al. Influence of cell proportions and proliferation rates on FDG uptake in squamous-cell esophageal carcinoma: a PET study[J]. Cancer Biother Radiopharma, 2008, 23(2): 172-180.
3
Han DL. Pathological validation of FLT PET-CT in delineating the biological target length of gross tumor in esophageal carcinoma[J]. Chinese Tournal of Radiation Oncology, 2010.
4
钟小军, 于金明, 张百江, 等. FDG PET-CT靶区勾画方法在食管癌中的比较及病理对照研究[J]. 中华放射肿瘤学杂志, 2008, 17(1): 22-25.
5
Han D, Yu J, Yu Y, et al. Comparison of (18) F-fluorothymidine and (18) F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus[J]. Int J Radiat Oncol Biol Phys, 2010, 76(4): 1235-1241.
6
Vali FS, Nagda S, Hall W, et al. Comparison of standardized uptake value-based positron emission tomography and computed tomography target volumes in esophageal cancer patients undergoing radiotherapy[J]. Int J Radiat Oncol Biol Phys, 2010, 78(4): 1057-1063.
7
Biehl KJ, Kong FM, Dehdashti F, et al. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small celllung cancer: is a single standardized uptake value threshold approach appropriate?[J]. J Nucl Med, 2006, 47(11): 1808-1812.
8
Nestle U, Kremp S, Schaefer-Schuler A, et al. Comparison of different methods for delineation of 18F-FDG PET positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cacer[J]. J Nucl Med, 2005, 46(8): 1342-1348.
9
Yu W, Fu XI, Zhang YJ, et al. GTV spatial conformity between different delineation methods by 18F-FDG PET/CT and pathology in esophageal cancer[J]. Radiother Oncol, 2009, 93(3): 441-446.
10
Mamede M, EI Fakhri G, ABREU-E-Lima P, et al. Pre-operative estimation of esophageal tumor metabolic length in FDG-PET images with surgical pathology confirmation[J]. Ann Nucl Med, 2007, 21(10): 553-562.
11
Moureau-Zabotto L, Touboul E, Lerouge D, et al. Impact of CT and 18F-fluoro-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal cancinoma[J]. Int J Radiat Oncol Biol Phys, 2005, 63(2): 340-345.
12
Jeganathan R, McGuigan J, Campbell F, et al. Does pre-operative estimation of oesophageal tumor metabolic length using 18F-fluoro-deoxyglucose PET/CTimages compare with surgical pathology length?[J]. Eur J Nucl Med Mol imaging, 2011, 38(4): 656-662.
13
Vrieze O, Haustermans K, De Wever W, et al. Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?[J]. Radiother Oncol, 2004, 73(3): 269-275.
14
Caldwell CB, Mah K, Skinner M, et al. Can PET provide the 3D extent of tumor motion for individualized internal target volumes? A phantom study of the limitation of CT and the promise of PET[J]. Int J Radiat Oncol Biol Phys, 2003, 55(5): 1381-1393.
15
Okubo M, Nishimura Y, Nakamatsu K, et al. Static and moving phantom studies for radiation treatment planning in a positron emission tomography and computed tomography (PET/CT) system[J]. Ann Nucl Med, 2008, 22(7): 579-586.
16
Hanna GG, van Sörnsen de Koste JR, Dahele MR, et al. Defining target volumes for stereotactic ablative radiotherapy of early-stage lung tumours: a comparison of three-dimensional 18F-fluorodeoxyglucose positron emission tomography and four-dimensional computed tomography[J]. Clinical oncology, 2012, 24(6): e71-e80.
17
Nestle U, Schaefer-Schuler A, Kremp S, et al. Target vol-ume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer[J]. Eur J Nucl Med Mol Imaging, 2007, 34(4): 453-462.
18
郭洪波, 于金明, 张百江, 等. 氟脱氧葡萄糖PET-CT确定食管癌淋巴结放疗靶区的可行性研究[J]. 中华放射肿瘤学杂志, 2007, 16(1): 10-14.
19
张建东, 于金明, 郭洪波, 等. PET/CT确定进展期食管癌临床分期价值的探讨[J]. 中华肿瘤防治杂志, 2009, 16(23): 1875-1877.
20
Minamimoto R, Senda M, Jinnouchi S, et al. Detection of lung cancer by FDG-PET cancer screening program: a nationwide Japanese survey[J]. Anticancer Res, 2014, 34(1): 183-189.
21
Shakespear W. FDG-PET in Oncology: There′s more to it than looking at picture[J]. J Nucl Med, 1993, 34(1): 6-11.
22
赵军, 林祥通, 管一晖, 等. 双时相PET现象在肺良恶性病变鉴别诊断中的应用[J]. 中华核医学杂志, 2003, 23(1): 8-10.
23
Lindholm P, Minn H, Leskinen-Kallio S, et al. Influence of the blood glucose concentration on FDG uptake in cancer-a PET study[J]. J Nucl Med, 1993, 34(1): 1-6.
24
Schmucking M, Baum RP, Bonnet R, et al. Correlation of histologic results with PET findings for tumor regression and survival in locally advanced non-small cell lung cancer after neoadjuvant treatment[J]. Pathology, 2005, 26(3): 178-189.
25
Adli M, Caglayan D, Koc M, et al. 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Maximum Standardized Uptake Value (SUVmax) as a Prognostic Factor in Non-Hodgkin Lymphoma Patients[J]. Int J Radiat Oncol Biol Phys, 2013, 87(2): S555-S556.
26
Bettinardi V, Picchio M, Di Muzio N, et al. Detection and compensation of organ/lesion motion using 4D-PET/CT respiratory gated acquisition techniques[J]. Radiother Oncol, 2010, 96(3): 311-316.
27
Wolthaus JW, van Herk M, Muller SH, et al. Fusion of respiration -correlated PET and CT scans: correlated lung tumour motion in anatomical and functional scans[J]. Phys Med Biol, 2005, 50(7): 1569-1583.
28
Ciernik IF, Dizendorf E, Baumert BG, et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study[J]. Int J Radiat Oncol Biol Phys, 2003, 57(3): 853-863.
29
Lagergren J, Smyth E, Cunningham D, et al. Oesophageal cancer[J]. Lancet, 2017, 390(10110): 2383-2396.
30
刘琪, 余雯, 蔡旭伟, 等. PET-CT用于评价食管鳞癌放疗中18F-FDG高摄取区域的空间动态变化的前瞻性研究[J]. 中国癌症杂志, 2016, 26(2): 161-167.
31
顾飞英, 蒋晨雪, 许亚萍, 等. FDG PET-CT在食管癌放化疗中的应用[J]. 中华放射肿瘤学杂志, 2017, 26(8): 961-964.
32
叶建平. (18)FDG PET-CT诊断食管癌淋巴结转移的优势及确定淋巴结放疗靶区的可行性分析[J]. 影像研究与医学应用, 2018, 2(12): 73-75.
[1] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[2] 胡文钰, 徐东东, 李南林. 早期乳腺癌全身辅助治疗的研究现状[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 297-303.
[3] 潘荔生, 刘忠强, 周莹莹, 陈勃, 李晏宁, 徐金锋, 蔡隆梅, 王宏梅. 乳腺癌内乳淋巴结的诊断和治疗[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 308-314.
[4] 浦凌宵, 诸俊浩, 陶亮, 王峰, 王萌, 管文贤. 低黏附性胃癌PET/CT影像学特征和脂代谢相关机制研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(03): 255-260.
[5] 谢汶歆, 马乐, 刘晔, 曹晓明, 张万春. 前列腺特异性膜抗原PET/CT在肾癌诊疗中的应用价值[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 514-519.
[6] 蔡定钦, 孙建国, 陈旭. 外泌体非编码RNAs与肺癌放射治疗的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 655-658.
[7] 陈旭, 牛凯, 孙建国. 放疗联合免疫治疗对驱动基因阴性NSCLC的困惑分析及应对策略[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(03): 341-348.
[8] 张瑜, 姜梦妮. 基于DWI信号值构建局部进展期胰腺癌放化疗生存获益预测模型[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 657-664.
[9] 段伟, 刘飞, 许光源, 程宇豪, 陈星. 食管癌调强放疗计划剂量学参数差异对放射性肺炎发生及严重程度的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 320-324.
[10] 陶金华, 陈珊珊, 陈晓四. 阿帕替尼联合替吉奥治疗晚期食管癌的疗效与安全性影响因素评价[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 325-329.
[11] 高建平, 王辉, 王淑萍. 定期家庭随访对胸腔镜食管癌术后饮食恢复功能的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(02): 188-192.
[12] 郑鑫蓥, 张惠勇, 黄星, 邱磊, 方庆亮, 鹿振辉, 王蕾. TGF-β在放射治疗中的双重调控作用[J/OL]. 中华临床医师杂志(电子版), 2024, 18(03): 309-314.
[13] 王超, 王浩, 孙柏, 袁野, 羌伟光, 石红兵. 卡非佐米联合碘-125粒子照射促进人食管癌细胞KYSE-150凋亡的机制研究[J/OL]. 中华介入放射学电子杂志, 2024, 12(02): 106-113.
[14] 高鹏强, 林军鹏, 王佩元, 林辉, 周航, 魏文巍, 柳硕岩, 王枫. 胸段食管鳞状细胞癌中锁骨上淋巴结转移对预后的影响:一项大型回顾性研究[J/OL]. 中华胸部外科电子杂志, 2024, 11(04): 211-218.
[15] 李春光, 杨洋, 李斌, 华荣, 李志刚. 完全腹腔镜下管状胃制作技术在食管癌McKeown手术中的应用[J/OL]. 中华胸部外科电子杂志, 2024, 11(04): 219-224.
阅读次数
全文


摘要